Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Combination of Ixekizumab and Tirzepatide Results in Enhanced Disease Management Compared to Ixekizumab Monotherapy in Adults with Psoriatic Arthritis and Overweight or Obesity

  • By

  • Joseph F. Merola

  • Cynthia E. Kartman

  • Peter Fischer

  • Luna Sun

  • Anabela Cardoso

  • Mark C. Genovese

  • Alexis Ogdie

  • June 11, 2026

Share

Original Source(s)

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity

  • by Joseph F. Merola, Cynthia E. Kartman, Peter Fischer, Luna Sun, Anabela Cardoso, Mark C. Genovese, Alexis Ogdie

  • June 11, 2026

Related Content

Pediatric Psoriasis: Comorbidities, Treatment Challenges and Unmet Needs

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

Case report : Early-Onset Juvenile Psoriatic Arthritis Presenting at 15 Months: A Diagnostic Challenge in Infancy